eDevice SA Assumes Commercialization of TwoCan Pulse from Boston Scientific

Cardio Partners Acquires One Beat Medical & Training

May 14, 2024

Healthcare Services

Cardio Partners, a division of Sarnova and part of Patricia Industries, has acquired One Beat Medical & Training, a Miramar, Florida-based distributor of automated external defibrillators (AEDs), accessories and CPR training services. The transaction, completed May 14, 2024, expands Cardio Partners' emergency preparedness product portfolio and training capabilities while increasing the combined organization's geographic reach across the United States.

Boston Scientific to Acquire Preventice Solutions for $925 Million

January 22, 2021

Healthcare Services

Boston Scientific entered into a definitive agreement to acquire Preventice Solutions, a private provider of mobile cardiac health monitoring solutions and services, for an upfront cash payment of $925 million. The deal also includes up to $300 million in potential commercial milestone payments and is expected to close by mid-2021 subject to customary conditions.

Boston Scientific to Acquire SoniVie Ltd

March 3, 2025

Medical Devices

Boston Scientific Corporation has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company developing the TIVUS intravascular ultrasound system for renal denervation therapy for hypertension. The deal includes an upfront payment of approximately $360 million for the 90% stake Boston Scientific does not already own, plus up to $180 million contingent on achievement of a regulatory milestone.

CardioOne Acquires CardioDiagnostics

April 24, 2025

Healthcare Services

CardioOne, a national growth and operational partner for independent cardiology practices, has acquired CardioDiagnostics, a provider of advanced ECG and remote patient monitoring (RPM) technologies. The deal integrates CardioDiagnostics’ cloud-based monitoring, analytics and RPM capabilities into CardioOne’s practice management platform to expand virtual care and enhance cardiology practice services.

Boston Scientific Investment Agreement with Exclusive Option to Acquire Farapulse, Inc.

September 21, 2020

Medical Devices

Boston Scientific Corporation signed an investment agreement that includes an exclusive option to acquire Farapulse, Inc., a privately held developer of pulsed field ablation technology for atrial fibrillation and other cardiac arrhythmias. Farapulse’s system uses irreversible electroporation (pulsed electric fields) to ablate heart tissue without thermal energy. The platform is investigational and not available for sale.

Royal Philips to Acquire BioTelemetry, Inc. for $2.8B

December 18, 2020

Healthcare Services

Royal Philips has agreed to acquire BioTelemetry, Inc. in a cash tender offer of USD 72.00 per share, implying an enterprise value of approximately USD 2.8 billion. The deal combines Philips' hospital patient-monitoring capabilities with BioTelemetry's remote cardiac diagnostics and monitoring services (which serve over 1 million patients annually and had 2019 sales of about USD 439 million) to expand Philips' patient care management offerings across hospital and home settings.